HSV-1 and HSV-2 are two closely related but distinct viruses. The biggest practical differences come down to where they prefer to live in the body, how often they flare up, and how common each one is. Both cause lifelong infections with similar-looking sores, but they behave differently enough that knowing which type you have changes what you can expect over time.
How Common Each Type Is
HSV-1 is far more widespread. An estimated 3.8 billion people under age 50, roughly 64% of the global population, carry it. Most people pick it up during childhood or young adulthood through non-sexual contact with saliva, like a kiss from a parent or sharing a drink. Between 50% and 80% of American adults have oral HSV-1.
HSV-2 is less common, infecting around 520 million people aged 15 to 49 worldwide, about 13% of that age group. It spreads almost exclusively through sexual contact. Despite the lower overall numbers, more than 1 in 5 adults globally are living with genital herpes when you count both types together, since HSV-1 increasingly causes genital infections too.
Where Each Type Prefers to Live
HSV-1 has traditionally been associated with oral herpes: cold sores or fever blisters on or around the lips. HSV-2 is considered the “genital” herpes virus, causing sores in the genital and anal area. But these categories are not rigid. HSV-1 can infect the genitals (typically through oral sex), and HSV-2 can occasionally appear on the mouth, though that’s much less common.
The reason each virus has a preferred location is that after the initial infection, herpes viruses retreat into nerve clusters near the site of infection and stay dormant there. HSV-1 typically settles into the nerve cluster near the base of the skull, while HSV-2 favors the nerve cluster at the base of the spine. When the virus reactivates, it travels back along those same nerves, which is why outbreaks tend to recur in the same area.
The Shift in Genital Herpes Cases
One of the most significant changes in recent decades is how many new genital herpes cases are caused by HSV-1 rather than HSV-2. As of 2020, an estimated 376 million people had genital HSV-1 infections globally. This shift likely reflects changing sexual practices and the fact that fewer young people are getting exposed to HSV-1 orally during childhood. Without existing antibodies from a childhood oral infection, they’re vulnerable to catching it genitally through oral sex later on.
You can also have both types at the same time. Roughly 50 million people with genital HSV-1 are estimated to also carry HSV-2.
Outbreaks and Recurrence
This is where the two types differ most in daily life. HSV-2 genital infections recur far more often than HSV-1 genital infections. Nearly all people with a symptomatic first episode of genital HSV-2 will have additional outbreaks. In the first year, that can mean four to six recurrences, though the frequency typically decreases over time.
Genital HSV-1, by contrast, recurs much less frequently. After the initial episode, outbreaks tend to drop off quickly, and viral shedding (the period when the virus is active on the skin without visible sores) decreases rapidly within the first year. Many people with genital HSV-1 have few or no recurrences after the first year.
Oral HSV-1 falls somewhere in between. Cold sores can recur periodically, often triggered by stress, illness, sun exposure, or fatigue, but most people experience them infrequently.
Asymptomatic Shedding
Both types can be transmitted even when no sores are visible, through a process called asymptomatic shedding. The virus periodically becomes active on the skin surface without causing noticeable symptoms. HSV-2 sheds asymptomatically at significantly higher rates than HSV-1, which is one reason it spreads so effectively. Even people with longstanding HSV-2 infections who have never noticed symptoms still shed the virus intermittently.
People with HSV-2 who have never had noticeable outbreaks shed about 50% less than those with symptomatic infections, but shedding still occurs. This is a key reason genital HSV-2 is harder to contain than genital HSV-1.
How Transmission Works
HSV-1 spreads through contact with infected saliva, oral skin, or genital skin and fluids. Because it’s so often acquired non-sexually in childhood, many people don’t realize they carry it. HSV-2 spreads through vaginal, anal, or oral sex with someone who has a genital infection. Neither virus spreads through toilet seats, bedding, swimming pools, or shared objects like towels or silverware.
Oral HSV-1 can spread to a partner’s genitals through oral sex, which is the primary driver behind the rise in genital HSV-1 cases. This can happen even when the person giving oral sex has no active cold sore.
How Testing Tells Them Apart
A swab of an active sore is the most reliable way to identify which type you have. Blood tests look for type-specific antibodies but come with some limitations. For HSV-2, the most widely used blood tests are quite accurate, with sensitivity above 97% and specificity above 98% on the best-performing platforms. For HSV-1, blood tests are less reliable. Sensitivity drops to around 80-84% on some platforms, meaning they miss a meaningful number of infections.
False positives are also a concern, particularly at low-positive results. One commonly used test produces false positive results for HSV-1 over 60% of the time when the result falls in the low-positive range. This is why a borderline blood test result, especially for HSV-1, often needs confirmation with a different test method.
Managing Outbreaks
Both types respond to the same antiviral medications. Treatment comes in two forms: episodic therapy (taking medication when you feel an outbreak starting) and suppressive therapy (taking a daily dose to prevent outbreaks). Suppressive therapy reduces the frequency of genital herpes recurrences by 70% to 80% in people who have frequent flare-ups.
Because genital HSV-1 recurs so much less often than genital HSV-2, many people with genital HSV-1 don’t need daily suppressive therapy. They may only need episodic treatment for the occasional outbreak, or no treatment at all if recurrences stop. People with genital HSV-2, particularly in the first few years after infection, are more likely to benefit from daily suppressive medication to reduce both outbreaks and the risk of transmitting the virus to partners.
Complications Worth Knowing About
For most healthy adults, herpes is more of a recurring nuisance than a serious health threat. But there are situations where the distinction between the two types matters medically.
HSV-2 infection roughly triples the risk of acquiring HIV, based on a meta-analysis of 55 prospective studies. The open sores and ongoing inflammation in genital tissue create easier entry points for HIV. HSV-1, while not harmless, has not been linked to HIV risk in the same way.
Neonatal herpes is a rare but serious concern during pregnancy. A first-time genital herpes infection late in pregnancy, whether HSV-1 or HSV-2, poses the highest risk to the newborn because the mother hasn’t had time to develop protective antibodies. The virus type matters less here than the timing: a brand-new infection near delivery is the leading risk factor.
The Biological Differences
Despite causing similar symptoms, HSV-1 and HSV-2 are genetically distinct enough that HSV-2 is actually more closely related to chimpanzee herpesvirus than it is to HSV-1. Both have genomes around 152 to 155 thousand base pairs of double-stranded DNA, but the proteins they produce differ in meaningful ways. HSV-2 mutates much faster than HSV-1, generating more genetic diversity. The majority of these mutations change the structure of viral proteins, which may help explain why HSV-2 is harder for the immune system to suppress and why it reactivates more frequently.